Shree Ganesh Remedies Ltd Financials
Company Logo

Shree Ganesh Remedies Ltd Financial Statement

Shree Ganesh Remedies Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue26.72
Operating Expense14.55
Net Profit6.60
Net Profit Margin24.70
Earning Per Share5.13
EBIDTA12.24
Effective Tax Rate18.59

Shree Ganesh Remedies Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual125.90
Operating Expenses Annual84.09
Operating Profit Annual44.88
Interest Annual0.60
Depreciation5.49
Net Profit Annual28.12
Tax Annual10.05

Shree Ganesh Remedies Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning8.66
Cash Flow from Operations30.45
Cash Flow from Investing-33.18
Cash Flow from Financing9.85
Cash Flow at the End15.78

Shree Ganesh Remedies Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)35.65
PBIT Margin (%)30.79
PBT Margin (%)-20.54
Net PROFIT Margin (%)22.34
Return On Networth / Equity (%)26.87
Return On Networth /Employed (%)27.76
Return On Assets (%)20.10
Total Debt / Equity (X)0.33
Asset Turnover Ratio (%)0.90

Shree Ganesh Remedies Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual80.84
Total Current Assets Annual70.13
Non Current Assets Annual100.82
Total Shareholders Funds Annual122.11
Total Assets Annual170.94

Shree Ganesh Remedies Ltd Earning Calls

EPS (INR)

Expected

5.13

Reported

5.13

Surprise

0.00%

Dec 2024

EPS beaten by 0.00%

Sep 2024

EPS beaten by 0.00%

Jun 2024

EPS beaten by -0.40%

FAQS on Shree Ganesh Remedies Ltd Financials

As of Jun 2, 2025, Shree Ganesh Remedies Ltd has a market capitalization of 913.01 Cr. Value Research classifies it as a Small-Cap company.

Yes, Shree Ganesh Remedies Ltd is with a debt-to-equity ratio of 0.26.

In FY 2024 , Shree Ganesh Remedies Ltd recorded a total revenue of approximately 108.60 Cr marking a significant milestone in the company's financial performance.

Shree Ganesh Remedies Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.5% and 0.1% annually, respectively..

Shree Ganesh Remedies Ltd's current PE ratio is 39.52.

Shree Ganesh Remedies Ltd's ROCE averaged 19.9% from the FY ending March 2023 to 2025, with a median of 18.2%. It peaked at 24.5% in March 2024, reflecting strong capital efficiency over the period..

Shree Ganesh Remedies Ltd's latest EBIT is Rs. 33.38 Cr, surpassing the average EBIT of Rs. 30.86 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions